MedTrace Logo

Factors Associated With the Acne Severity Among Transmen Population: a Cross-sectional Study

NCT06149065 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 247

Last updated 2023-11-28

No results posted yet for this study

Summary

The goal of this observational cross-sectional study is to identify factors associated with severity of acne in Thai transmen receiving masculinizing hormone therapy. The main questions it aims to answer are:

* What are the factors associated with severity of acne in transmen?
* Does masculinizing hormone therapy associate with the severity of acne in transmen? Participants will be asked to complete an online questionnaire and allow to take pictures of their face for acne assessment purpose.

Conditions

  • Acne
  • Transgenderism

Interventions

DRUG

Testosterone

Masculinizing hormone therapy (testosterone) is used in female-to-male transgenders for medical reason.

Sponsors & Collaborators

  • Mahidol University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-05
Primary Completion
2023-06-06
Completion
2023-06-06

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06149065 on ClinicalTrials.gov